Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 54 articles: HTML format Text format

Single Articles

October 2019
1. PAROVICHNIKOVA E, Troitskaya V, Sokolov A, Gavrilina O, et al
   Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
   Acta Haematol. 2019 Oct 9:1-9. doi: 10.1159/000502435.
   PubMed     Text format     Abstract available
   
   
   
2. SAUSSELE S, Haverkamp W, Lang F, Koschmieder S, et al
   Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
   Acta Haematol. 2019 Oct 7:1-15. doi: 10.1159/000501927.
   PubMed     Text format     Abstract available
   
   
   September 2019
3. PAN P, Wang L, Wang Y, Shen L, et al
   Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia.
   Acta Haematol. 2019 Sep 12:1-13. doi: 10.1159/000501537.
   PubMed     Text format     Abstract available
   
   
   August 2019
4. JIANG H, Li C, Liu Z
   Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
   Acta Haematol. 2019 Aug 21:1-9. doi: 10.1159/000500822.
   PubMed     Text format     Abstract available
   
   
   July 2019
5. KEMPIN S, Sun Z, Kay NE, Paietta EM, et al
   Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
   Acta Haematol. 2019 Jul 23:1-9. doi: 10.1159/000500164.
   PubMed     Text format     Abstract available
   
   
   
6. BRUNNER AM
   Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
   Acta Haematol. 2019 Jul 17:1-2. doi: 10.1159/000501330.
   PubMed     Text format    
   
   
   
7. SHIMONY S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, et al
   Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.
   Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975.
   PubMed     Text format     Abstract available
   
   
   
8. LI Y, You MJ, Yang Y, Hu D, et al
   The Role of Tumor-Associated Macrophages in Leukemia.
   Acta Haematol. 2019 Jul 9:1-6. doi: 10.1159/000500315.
   PubMed     Text format     Abstract available
   
   
   
9. SCHALLER T, Herold N
   Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia.
   Acta Haematol. 2019 Jul 8:1-2. doi: 10.1159/000501148.
   PubMed     Text format    
   
   
   June 2019
10. GUO Z, Chen Z, Xu Y, Zhang Y, et al
    The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Jun 18:1-7. doi: 10.1159/000500588.
    PubMed     Text format     Abstract available
    
    
    
11. ZHANG Y, Gu H, Chen Q, Zhang Y, et al
    Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2019 Jun 5:1-10. doi: 10.1159/000500230.
    PubMed     Text format     Abstract available
    
    
    May 2019
12. SANTOPIETRO M, Miano M, Palumbo G, Zhang K, et al
    Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
    Acta Haematol. 2019 May 21:1-2. doi: 10.1159/000497137.
    PubMed     Text format    
    
    
    
13. BRECCIA M
    Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data.
    Acta Haematol. 2019 May 21:1-3. doi: 10.1159/000496449.
    PubMed     Text format    
    
    
    
14. ZENG Z, Liu W, Benton CB, Konoplev S, et al
    Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2019 May 21:1-9. doi: 10.1159/000495456.
    PubMed     Text format     Abstract available
    
    
    April 2019
15. FELD J, Arnason J, O Apos Brien K, Nahas M, et al
    Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Acta Haematol. 2019;141:222-224.
    PubMed     Text format    
    
    
    February 2019
16. LI Z, Liu Y, Wang Q, Chen L, et al
    Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.
    Acta Haematol. 2019;141:164-175.
    PubMed     Text format     Abstract available
    
    
    
17. TAHARA K, Koiso H, Osaki YH, Sekigami T, et al
    Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappaB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2019;141:135-137.
    PubMed     Text format    
    
    
    January 2019
18. BIELORAI B, Leitner M, Goldstein G, Mehrian-Shai R, et al
    Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Acta Haematol. 2019;141:119-127.
    PubMed     Text format     Abstract available
    
    
    
19. EL CHAER F, Holtzman NG, Sausville EA, Law JY, et al
    Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
    Acta Haematol. 2019;141:107-110.
    PubMed     Text format     Abstract available
    
    
    
20. SCHNEIDEWIND L, Neumann T, Zimmermann K, Weigel M, et al
    Is BK Virus-Associated Cystitis a Generalized Epithelial Disease?
    Acta Haematol. 2019;141:65-67.
    PubMed     Text format     Abstract available
    
    
    
21. RUIZ-ARGUELLES GJ
    Factors Involved in the Selection of Treatment in Patients with Hematological Malignancies.
    Acta Haematol. 2019;141:54.
    PubMed     Text format    
    
    
    
22. SHARGIAN-ALON L, Raanani P, Rozovski U, Siegal T, et al
    Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Acta Haematol. 2019;141:19-22.
    PubMed     Text format     Abstract available
    
    
    December 2018
23. WANG L, Xu J, Tian X, Lv T, et al
    Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Acta Haematol. 2018;141:43-53.
    PubMed     Text format     Abstract available
    
    
    November 2018
24. ABRUZZESE E, Trawinska MM, Neri B, Bondanini F, et al
    Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
    Acta Haematol. 2018;140:231-233.
    PubMed     Text format    
    
    
    October 2018
25. CHOTSAMPANCHAROEN T, Sripornsawan P, Duangchu S, Wongchanchailert M, et al
    Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children.
    Acta Haematol. 2018;140:203-208.
    PubMed     Text format     Abstract available
    
    
    
26. NACHMIAS B, Shaulov A, Gatt ME, Shapira M, et al
    A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
    Acta Haematol. 2018;140:209-214.
    PubMed     Text format     Abstract available
    
    
    
27. JIANG L, Deng T, Wang D, Xiao Y, et al
    Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:183-192.
    PubMed     Text format     Abstract available
    
    
    September 2018
28. GIONA F, Santopietro M, Menna G, Putti MC, et al
    Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
    Acta Haematol. 2018;140:105-111.
    PubMed     Text format     Abstract available
    
    
    
29. NAESENS L, Devos H, Nollet F, Michaux L, et al
    Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Acta Haematol. 2018;140:97-104.
    PubMed     Text format     Abstract available
    
    
    
30. HA M, Kim JY, Han ME, Kim GH, et al
    TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:71-76.
    PubMed     Text format     Abstract available
    
    
    August 2018
31. ROZOVSKI U, Keating MJ, Estrov Z
    Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
    Acta Haematol. 2018;140:51-54.
    PubMed     Text format     Abstract available
    
    
    
32. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
    A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:30-39.
    PubMed     Text format     Abstract available
    
    
    June 2018
33. PARK HS, Kim DY, Choi EJ, Lee JH, et al
    Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Acta Haematol. 2018;139:220-227.
    PubMed     Text format     Abstract available
    
    
    March 2018
34. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.
    PubMed     Text format    
    
    
    February 2018
35. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Text format     Abstract available
    
    
    
36. BRUNNER AM
    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.
    PubMed     Text format    
    
    
    
37. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Text format     Abstract available
    
    
    
38. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Text format     Abstract available
    
    
    January 2018
39. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.
    PubMed     Text format    
    
    
    
40. LV H, Hu S, Lu J, Zhai Q, et al
    Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Acta Haematol. 2018;139:176-182.
    PubMed     Text format     Abstract available
    
    
    September 2017
41. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.
    PubMed     Text format    
    
    
    
42. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed     Text format    
    
    
    
43. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    
    
    
    July 2017
44. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available
    
    
    
45. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available
    
    
    
46. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    
    
    
    June 2017
47. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available
    
    
    May 2017
48. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    
    
    
    April 2017
49. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available
    
    
    
50. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    
    
    
    
51. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available
    
    
    January 2017
52. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available
    
    
    
53. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available
    
    
    
54. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: